×
About 518 results

ALLMedicine™ Spinal Cord Tumors Center

Research & Reviews  187 results

Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers
https://clinicaltrials.gov/ct2/show/NCT03173950

Jun 24th, 2022 - Background: There are more than 130 identified primary tumors of the central nervous system (CNS). Most have an annual incidence of less than 1000 in the United States. Given the rarity of each of the tumors listed above, there is a paucity of pro...

Spinal Ependymoma (Ependymal Tumor) Imaging
https://emedicine.medscape.com/article/345221-overview

Jun 14th, 2022 - Practice Essentials Ependymomas (ependymal tumors) are believed to account for approximately 60% of all primary neoplasms of the spinal cord and filum terminale. Intraspinal ependymomas are most easily grouped into 3 classes: intramedullary lesion...

Spinal Ependymoma (Ependymal Tumor) Imaging
http://emedicine.medscape.com/article/345221-overview

Jun 14th, 2022 - Practice Essentials Ependymomas (ependymal tumors) are believed to account for approximately 60% of all primary neoplasms of the spinal cord and filum terminale. Intraspinal ependymomas are most easily grouped into 3 classes: intramedullary lesion...

Spinal Ependymoma (Ependymal Tumor) Imaging
https://emedicine.medscape.com/article/345221-print

Jun 14th, 2022 - Ependymomas (ependymal tumors) are believed to account for approximately 60% of all primary neoplasms of the spinal cord and filum terminale. Intraspinal ependymomas are most easily grouped into 3 classes: intramedullary lesions, myxopapillary epe...

Astrocytoma Spinal Imaging
https://emedicine.medscape.com/article/345105-overview

Jun 1st, 2022 - Practice Essentials Astrocytomas of the spinal cord are rare tumors that arise from astrocytes in the spinal cord and occur in both adult and pediatric populations. [1, 2, 3, 4] Most spinal cord astrocytomas are benign, low-grade tumors that are r...

see more →

Clinicaltrials.gov  7 results

Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers
https://clinicaltrials.gov/ct2/show/NCT03173950

Jun 24th, 2022 - Background: There are more than 130 identified primary tumors of the central nervous system (CNS). Most have an annual incidence of less than 1000 in the United States. Given the rarity of each of the tumors listed above, there is a paucity of pro...

Natural History of Patients With Brain and Spinal Cord Tumors
https://clinicaltrials.gov/ct2/show/NCT00009035

Dec 12th, 2019 - Background: This protocol is designed to evaluate patients with tumors of the central nervous system (CNS) who appear to be probable candidates for future protocol entry or have disease manifestations that are of unique scientific interest, import...

Spinal Motor Evoked Potentials in Brain Surgery
https://clinicaltrials.gov/ct2/show/NCT02402075

Mar 30th, 2015 - During neurosurgical resection of brain tumors within brain areas for motor control, it is important to monitor motor function. For this muscle motor evoked potentials are used. Those are elicited by transcranial and direct cortical stimulation. M...

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors
https://clinicaltrials.gov/ct2/show/NCT00003141

Mar 28th, 2014 - OBJECTIVES: Determine the maximum tolerated dose of thiotepa in infants with malignant brain or spinal cord tumors receiving intensive chemotherapy. Determine the feasibility and toxicity of intensive chemotherapy with peripheral blood stem cell (...

Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors
https://clinicaltrials.gov/ct2/show/NCT01076530

May 3rd, 2013 - PRIMARY OBJECTIVES: I. To estimate the maximum tolerated dose and/or recommended phase II dose of vorinostat in combination with temozolomide in pediatric patients with relapsed or refractory primary CNS tumors. II. To define and describe the toxi...

see more →

News  6 results

Medical tourism for MS stem cell therapy is common
https://www.mdedge.com/neurology/article/195492/multiple-sclerosis/medical-tourism-ms-stem-cell-therapy-common
Kari Oakes

Mar 2nd, 2019 - DALLAS – “Stem cell therapy is something that has been a topic of interest for neurologists for a while,” said Wijdan Rai, MD, speaking at the meeting presented by the American Committee for Treatment and Research in Multiple Sclerosis. However, “.

CyberKnife Real-Time Image-Guided Radiosurgery Treats Spinal Tumors
https://www.medscape.com/viewarticle/453141

Apr 29th, 2003 - April 29, 2003 -- The CyberKnife Real-Time Image-Guided Radiosurgery system is safe and effective for spinal tumors not amenable to an open operative approach, according to an oral presentation at the American Association of Neurological Surgeons ...

Misdiagnosing Tick Paralysis Can Lead to Death in 10%
https://www.mdedge.com/pediatrics/article/40190/infectious-diseases/misdiagnosing-tick-paralysis-can-lead-death-10
Bruce Jancin

VAIL, COLO. — Tick paralysis is often misdiagnosed—with potentially dire consequences—as one of the other diseases that cause an acute ascending paralysis with preserved mental status.

Tick Paralysis Is Easily Treated But Often Missed
https://www.mdedge.com/dermatology/article/17448/infectious-diseases/tick-paralysis-easily-treated-often-missed
Bruce Jancin

VAIL, Colo. - Tick paralysis is often misdiagnosed - with potentially dire consequences - as one of the other diseases that cause an acute ascending paralysis with preserved mental status.

Misdiagnosed Tick Paralysis Fatal in About 10% of Cases
https://www.mdedge.com/familymedicine/article/31701/infectious-diseases/misdiagnosed-tick-paralysis-fatal-about-10-cases
Family Practice News; Bruce Jancin

VAIL, COLO. — Tick paralysis is often misdiagnosed — with potentially dire consequences — as one of the other diseases that cause an acute ascending paralysis with preserved mental status.

see more →

Patient Education  7 results see all →